Lv4
708 积分 2024-10-14 加入
Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside
2天前
已完结
First-in-human study of the theranostic pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in pancreatic adenocarcinoma
2天前
已关闭
A High-Affinity Antibody-Drug Conjugates Actuximab-MMAE for Potent and Selective Targeting of CEACAM5-Positive Tumors
2天前
已完结
First-In-Human Pilot PET Immunoimaging Study of 64Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers
2天前
已完结
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
6天前
已完结
Prediction of early biochemical response after 177Lu-PSMA radioligand therapy with 68Ga-PSMA PET, a different perspective with quantitative parameters
6天前
已完结
Prognostic [68Ga]Ga‐PSMA‐11 PET Biomarkers for [177Lu]Lu‐PSMA Radioligand Therapy in Metastatic Castrate‐Resistant Prostate Cancer (Asian Population Study)
7天前
已完结
Comparison of the tracer uptake into the kidneys in GA68-PSMA-PET-CT and the absorbed dose per applied GBq Lu177-PSMA-617 during a following therapy
7天前
已关闭
Prediction of [177Lu]Lu-PSMA-617 Treatment Response with [68Ga]Ga-PSMA-11 PET-Derived Variables and Correlation of the Overall Survival with Serum PSA and PSMA PET-based Response Criteria
7天前
已完结
The gradient-like separation and reduced running time with Tris-Tricine-HEPES buffer for SDS-PAGE
12天前
已完结
皖公网安备34019202002308
